Bio-Works continues investing in the Indian market with BioLinx India as distributor and Dr Ravi Rayanade as Director Regional Sales, India
Bio-Works Technologies (Nasdaq First North) recently signed a distribution agreement with BioLinx India Pvt Ltd, Mumbai, to import, distribute, promote and sell all its products in India to Academia, Hospitals & Clinics and Biotech SMEs. Bio-Works has also engaged Dr Ravi Rayanade as Director Regional Sales. Dr Rayanade is a seasoned bioprocess expert with a wide network in the Indian biotech industry.
Bio-Works is further strengthening its presence in the Indian market to take advantage of the many opportunities arising from local companies’ expertise in developing new vaccines and biopharmaceuticals. These new vaccines and therapies are based on proteins, peptides or oligonucleotides. Many Indian biotech companies have more than 20 years’ experience in bioprocessing and continue to develop their strength as a low-cost manufacturing base for the global markets.
The Indian biopharma industry is growing at 12 percent yearly. According to the 15th Bio-Spectrum Biopharma Survey result for the year 2018-19, the biopharma industry revenues surpassed USD 3bn. The previous year’s revenue was USD 2.4bn. India has more than 40 innovative Biopharma companies ranging from start-ups to well-established players. The Indian chromatography market is estimated to be worth USD 65mn and the pre-packed chromatography columns market is anticipated to exhibit lucrative growth owing to the increased R&D efforts of the biopharmaceutical and academic sectors. An important market driver is the rapid increase in the demand for biopharmaceutical products such as vaccines and monoclonal antibodies.
Bio-Works’ proprietary agarose resins, WorkBeads™, have a wide variety of functionalities: WorkBeads affimAb for protein A-based affinity, WorkBeads 40Q, WorkBeads 40S and WorkBeads 40 TREN for ion-exchange, WorkBeads 40/100/1000/10000 SEC for size exclusion and WorkBeads 40 IDA, WorkBeads 40 NTA and WorkBeads 40 NiMAC for immobilised metal ion affinity chromatography. They are all specifically developed with commercial scale manufacturing in mind. WorkBeads, with stronger and more rigid agarose beads, offer faster mass transport, higher yields and higher purity offering opportunities for process intensification, which may result in a lower CoGS than competitors.
“Bio-Works’ is encouraged by the high level of competence in downstream processing in India, which we have encountered when meeting potential customers through Dr Rayanade’s network. In many cases, the knowledge and level of expertise is on a par with the US and European biopharma companies, which facilitates our technical sales process and which is also reflected in the positive test results we have seen from many local customers. We see a solid foundation in India with great opportunities to increase sales and expectations going forward”, says Mr Jonathan Royce, Bio-Works’ CEO.
“The addition of Bio-Works’ products has significantly strengthened our portfolio and our offering to the BioPharma and Drug Discovery segments. Over the last decade we have been steadily adding more and more products to our portfolio, catering to segments such as the Stem Cell Industry, Molecular Diagnostics, Drug Discovery and Biopharma, so Bio-Works is a very welcome addition. It also gives us an opportunity to be a part of Biopharma’s innovative research and manufacturing in the future.” says Mr. Girish Nair Founder and Managing Director of BioLinx India Pvt Ltd.
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Jonathan Royce, CEO, e-mail: jonathan.royce @ bio-works.com, phone: +46 70 1434143.
About Bio-Works
Bio-Works designs, develops, manufactures and supplies innovative leading-edge agarose products for chromatographic separation of proteins, peptides and other biomolecules. Bio-Works agarose based high performance products are used for purification in the life science research phases as well as the commercial production of biopharmaceuticals and diagnostic products in large scale. The products are sold globally with its own organization and via distributors. The Bio-Works’ headquarters with R&D and manufacturing is located in Uppsala Business Park in Uppsala, Sweden and the company processes and Quality Management System follow the standards of ISO 9001:2015. The company’s share is listed on Nasdaq First North. FNCA Sweden AB, +46 (0) 8-528 00 399, info@fnca.se, is appointed Certified Adviser.
About BioLinx India Pvt.
BioLinx India Pvt. Ltd.BioLinx India Pvt. Ltd. was formed in early 2008 with an idea of linking the scientific community to novel and cutting edge technology for improving their research activities. Backed by their excellent infrastructural facility and a dedicated group of professionals they have succeeded in establishing themselves as a preferred and reliable source of laboratory, medical, scientific and research equipment and ancillaries. They empower the scientific community by providing quick access to state-of-the art equipment, tools and services. Their mission is to present their customers with equipment and services to accelerate their research activities, with the vision of enabling customers to focus on their innovation and betterment of society at large. (For more information, please visit BioLinx India Pvt. Ltd. homepage, www.biolinxindia.com or contact Mr. Girish Nair; email: girish.nair@biolinxindia.com ).
About Dr Ravi Rayanade, Director Regional sales, India
Dr Rayanade is a scientist with over 25 years expertise and experience in the field of virology, immunology, cell biology and molecular biology. He has worked in reputed institutes in India and abroad, for example, National Institute of Virology, India, New York Medical College, NY, and Memorial Sloan-Kettering Cancer Centre, NY. He has substantial knowledge in viral safety, viral clearance studies, bioassay development, cell banking and cell characterization, vaccine, antiviral and anticancer drug development. He has worked with Indian Pharmaceutical companies as well as European Companies engaged in providing bio-services to Indian Biotechnology Industry. He serves at key positions in many organizations; as Director at Biosciences Consultancy and services based in Mumbai, as Technical Director at Mylab Discovery Solutions Pvt. Ltd., Pune, as Consultant to Arihant Innochem Pvt., Mumbai etc. He has wide experience in business development, deal negotiations with European, American and Indian companies as well as sound understanding of the life science industry and market in India. He has a strong network with Indian Biopharmaceutical industry and Academic Institutes and Universities in India.